Lampgen Clinical Research was founded in 2015 with one goal in mind: providing clinical operation expertise through staffing solutions for Sponsors and Contract Research Organizations. Our first clinical research consultant provided monitoring support for multiple clients with diverse projects ranging from a Phase 2 pediatric overactive bladder trial to a Phase III Melanoma project. Since our inception, we have provided CRA support for clinical projects for 9 of the top 10 pharmaceutical companies and 5 of the top 6 contract research organizations. Eventually, a growing oncology-focused pharmaceutical company requested our services for monitoring their entire Phase II and Phase III portfolio. This project launched our first CRO service offering. Today, Lampgen Clinical Research has evolved into a niche oncology CRO that offers multiple clinical development services to companies focused on bringing new cancer therapies to market. Our employees and contractors average 8 to 10 years of experience in the life sciences industry and are all trained on current EDC, CTMS, and IVRS application. As our company has evolved, so has our primary goal: Our focus is supporting our clients and their oncology assets on the entire journey to FDA approval, from the lab to the pharmacy.